Coronary artery cross-section with deployed wire-mesh stent across atherosclerotic plaque, copper eclipse arc curving around the vessel, fading into a blue molecular cosmic network.

An 80% coronary blockage at 44 changed how I evaluate every health claim.

Calibrated Signal examines cardiovascular risk, longevity claims, diagnostics, supplements, and wellness advice through the biology of aging, clinical medicine, bioinformatics, and an insider’s understanding of how wellness marketing really works.

  • Metabolic dysfunction
  • Genomic instability
  • Chronic inflammation
  • Cellular senescence
  • Mitochondrial dysfunction
  • Disrupted cell signaling
  • Stem cell exhaustion
  • Epigenetic alterations
  • Protein misfolding
  • Telomere shortening
  • Autophagy decline
  • Disrupted microbiome
  • Thymus involution

No sponsors.  ·  No supplement line.   ·  No hype.

The Four Worlds

Four worlds that shape how I evaluate every health claim.

Bedside

Where statistics become clinical judgment.

A p-value is not a patient. Bedside medicine trains you to separate statistical significance from clinical significance, and to ask whether a finding actually changes risk, decisions, or outcomes.

Mayo Clinic ED RN, CEN. APRN-FNP candidate at Duke.

Bench

Where health claims meet biological mechanism.

Bench science, molecular biology, and bioinformatics train you to ask what a claim is actually acting on: which pathway, which hallmark of aging, which molecular signal, and whether the data supports the story being sold.

MS, Bioinformatics & Computational Biology. Published epigenetics and oncology research. PhD candidate — UMN/Mayo Clinic.

Boardroom

Where plausible mechanisms become marketing copy.

Fifteen years inside the supplement and wellness industry taught me how health claims get built: how mechanisms become promises, how weak evidence gets inflated, and how incentives shape what consumers are told.

Former supplement industry CEO. No supplement line. No supplement affiliates. No sponsors. Ever.

Patient

Where the optimization playbook missed the risk.

At 44, an 80% coronary blockage forced me to confront the gap between predominant biohacker influencer advice and real cardiovascular risk. I was doing many of the things the longevity world celebrates, but the narrative was incomplete.

The Five Filters

A repeatable framework for evaluating health and longevity claims before they become advice.

Aging Biology

What biology is this supposed to change?

Which hallmarks of aging, upstream systems, or molecular pathways does the claim touch?

Clinical Reality

Does it matter in actual humans?

Is the effect meaningful for real people, or does it mostly live in a biomarker, dish, mouse, or marketing deck?

Evidence Quality

How strong is the evidence?

Is the claim supported by hard outcomes, randomized trials, human biomarkers, observational data, animal models, cell studies, or mechanism alone?

Systems Biology

What happens when you push the pathway?

Biology is not a single switch. What else does the pathway do in context, and what tradeoffs might come with moving it?

Incentives

Who benefits if you believe it?

Who profits if the claim becomes popular, and who pays the price if it is wrong?

Why This Exists

The near miss that made me build this.

Coronary Angiogram

Stent placement restores blood flow

Before stent

After stent

Coronary angiogram comparison: left panel shows severe narrowing limiting blood flow at the lesion site (orange circle); right panel shows the same artery after stent placement with restored vessel patency and improved blood flow (orange circle).

Blockage

Severe narrowing limits blood flow beyond this point.

Stent placed

Restored vessel patency with improved blood flow.

Circle indicates treated lesion site.

I was the “optimized” biohacker. Standard testing didn’t catch what mattered.

Low-carb diet. Daily exercise. Normal labs. Solid CGM results. I had the devices, the supplements, the metrics, and the standard high-performance playbook.

But reassuring signals are not the same thing as knowing your risk.

Routine testing did not show the disease building inside my coronary arteries. I had vague palpitations and chest discomfort, but nothing that felt alarming. Initial labs and diagnostic testing looked perfect. My cardiologist was reassured, but I still felt like something was off. I had to push for the right imaging.

That imaging found an 80% blockage.

If the system can nearly miss obstructive coronary disease in someone with high health literacy and access, what are we missing in everyone else?

That gap between reassurance and reality is why Calibrated Signal exists.